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 2 
ABSTRACT 1 
 To elucidate the checkpoint mechanism responsible for slowing passage through S phase 2 
when fission yeast cells are treated with the DNA-damaging agent, methyl methane sulfonate 3 
(MMS), we carried out 2D-gel analyses of replication intermediates in cells synchronized by 4 
cdc10 block (in G1) followed by release into synchronous S phase. The results indicated that 5 
under these conditions early-firing centromeric origins were partially delayed, but late-firing 6 
telomeric origins were not delayed. Replication intermediates persisted in MMS-treated cells, 7 
suggesting that replication fork movement was inhibited. These effects were dependent on the 8 
Cds1 checkpoint kinase and were abolished in cells overexpressing the Cdc25 phosphatase, 9 
suggesting a role for the Cdc2 cyclin-dependent kinase. We conclude that both partial inhibition 10 
of the firing of a subset of origins and inhibition of replication fork movement contribute to the 11 
slowing of S phase in MMS-treated fission yeast cells. 12 
13 
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 3 
INTRODUCTION 1 
 In response to low levels of the DNA-alkylating agent, methyl methane sulfonate (MMS), 2 
wild-type yeast cells slow their progression through S phase, while cells lacking the appropriate 3 
upstream checkpoint kinase (Mec1 in the budding yeast, Saccharomyces cerevisiae; Rad3 in the 4 
fission yeast, Schizosaccharomyces pombe) or the appropriate downstream checkpoint kinase 5 
(Rad53 in budding yeast, Cds1 in fission yeast) fail to do so. Other DNA-damaging agents also 6 
cause a checkpoint-dependent slowing of S phase—in vertebrates as well as in yeasts. This 7 
slowing of S phase in response to DNA damage is sometimes called the “intra-S-phase” 8 
checkpoint (3, 6, 22, 23, 26, 28, 36, 37, 45, 53). Here we shall refer to it as the “S-phase damage” 9 
checkpoint. 10 
 Prior to this report, the downstream portions of the checkpoint pathway(s) that slow S 11 
phase in response to DNA damage were unclear in fission yeast. However, the upstream portions 12 
of these pathways have been partially elucidated—in fission yeast and other organisms—and 13 
downstream mechanisms have been partially clarified in other organisms. In all studied systems, 14 
upon detection of DNA damage in S phase, checkpoint proteins initiate a phosphorylation 15 
cascade that ultimately leads to slowing of replication. Upstream signaling in these systems 16 
involves the activation of one or more of the PI3-kinase-like protein kinases (PIK kinases; ATR 17 
and/or ATM in humans, Mec1 and/or Tel1 in budding yeast and Rad3 in fission yeast). The 18 
activated PIK kinases then phosphorylate several proteins, including certain Ser/Thr kinases 19 
(Chk1 and/or Chk2 in humans, Rad53 in budding yeast and Cds1 in fission yeast). These kinases, 20 
in turn, phosphorylate other substrates that, directly or indirectly, mediate the slowing of S phase 21 
(reviewed in (3)). 22 
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 In budding yeast, two different mechanisms were shown to slow S phase upon DNA 1 
damage by MMS. Of these, one mechanism—inhibition of late-firing origins—depended on the 2 
Mec1-Rad53 checkpoint pathway (45, 53), while the other mechanism—inhibition of replication 3 
forks—appeared to be a direct consequence of DNA damage rather than a result of checkpoint 4 
activation (53). Tercero and Diffley (53) found that, in MMS-treated cells with mutations in the 5 
RAD53 gene, unregulated origin firing compensated for checkpoint-independent replication fork 6 
slowing, thus permitting a relatively normal overall rate of DNA synthesis. The mechanism by 7 
which the Rad53 protein modulates late origin activity is not yet clear, but one possibility is 8 
inhibition (by Rad53-catalyzed phosphorylation) of Dbf4, the regulatory subunit of the Cdc7-9 
Dbf4 kinase, which is essential for initiation of replication (7, 8, 14, 55). 10 
 In vertebrates, at least three different pathways have been shown to contribute to the 11 
slowing of S phase after DNA damage. In some cases checkpoint-mediated phosphorylation of 12 
Dbf4 inhibits progression through S phase by down-regulating origin firing (7, 14), as may take 13 
place in budding yeast. In other cases, checkpoint-mediated phosphorylation leads to inhibition 14 
and destruction of the protein phosphatase, Cdc25A, which is an activator of Cdk2. Cdk2 is the 15 
S-phase-specific cyclin-dependent kinase. Cdk2 activity is crucial for initiation of DNA 16 
replication and is modulated by inhibitory phosphorylation at Tyr-15. Cdc25A activates Cdk2 by 17 
dephosphorylating Tyr-15. Thus, when Cdc25A is phosphorylated by checkpoint kinases after 18 
DNA damage and subsequently destroyed, Cdk2 can no longer promote initiation of DNA 19 
replication (9, 27). The third mechanism by which vertebrate cells can slow progression through 20 
S phase is inhibition of replication fork movement. In contrast to budding yeast, where slowing 21 
of replication forks in response to DNA damage appeared to be checkpoint-independent, in 22 
vertebrate cells such slowing is frequently checkpoint-dependent. In the tested cases, fork 23 
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 5 
slowing has proved to be dependent on the PIK kinase, ATR (homologous to budding yeast 1 
Mec1 and fission yeast Rad3), and on the Ser/Thr kinase, Chk1 (a functional analogue of 2 
budding yeast’s Rad53 and fission yeast’s Cds1). In each of these cases, the checkpoint response 3 
to DNA damage led to inhibition of origin firing as well as to inhibition of replication fork 4 
movement (42, 44, 54). The precise mechanism leading to slowing of replication-fork movement 5 
has not been fully worked out, but the mechanism appears to involve interactions between Chk1 6 
and the proteins Tim and Tipin (54), whose yeast homologues (Swi1 and Swi3 in fission yeast, 7 
Tof1 and Csm3 in budding yeast) form a “replication-fork-protection complex” that is associated 8 
with replication forks (19, 33). 9 
 Although it is clear that slowing of S phase in response to MMS-induced DNA damage in 10 
fission yeast requires both the Rad3 and Cds1 kinases, the pathways operating downstream of 11 
Cds1 have been uncertain. We obtained results indicating that Cdc25, which was already known 12 
to be a target of Cds1 in hydroxyurea-treated (HU-treated) cells, is also a target of Cds1 in 13 
MMS-treated cells, because both overproduction of Cdc25 and conversion of Tyr-15 on Cdc2 14 
(the major cyclin-dependent kinase of fission yeast; also known as Cdk1) to a non-15 
phosphorylatable residue (Cdc2-Y15F; this mutation rendered Cdc2 constitutively active) were 16 
sufficient to prevent MMS-induced slowing of S phase (23). We concluded that, in fission yeast, 17 
the Rad3 ? Cds1  Cdc25 ? Cdc2 pathway forms a checkpoint-signaling module very similar 18 
to the corresponding one of vertebrates. However, Kommajosyula and Rhind were not able to 19 
repeat our observations regarding the roles of Cdc25 and Cdc2 (22), so the relevance of Cdc25 20 
and Cdc2 to checkpoint-induced slowing of S phase in fission yeast has remained uncertain until 21 
now. In addition, whether S phase in MMS-treated fission yeast cells is slowed by inhibition of 22 
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 6 
origin firing, by reduction in rate of fork movement, or by a combination of these has been 1 
equally unclear. 2 
 In order to resolve these issues, we initiated the series of experiments reported in this 3 
paper. To measure the rate of progression through S phase, we followed S phase by flow 4 
cytometry and by 2D gel electrophoresis in cells released from a G1 block (achieved by 5 
incubating cells bearing a cdc10 temperature-sensitive mutation at restrictive temperature, then 6 
releasing to permissive temperature (21, 23)). We found that in MMS-treated, checkpoint-7 
competent cells, the firing of early origins near centromeres was partially delayed, but the firing 8 
of late origins near telomeres was unaffected. Furthermore, the life-times of replication 9 
intermediates were prolonged, consistent with slowing of replication forks. These effects were 10 
completely abrogated both in cells lacking the Cds1 kinase and in cells overproducing the Cdc25 11 
phosphatase, showing that these effects were checkpoint-dependent and that the relevant 12 
checkpoint pathway probably involved inhibition of Cdc25. 13 
 14 
MATERIALS AND METHODS 15 
 Strains and growth conditions. The fission yeast strains used in this study are: (i) 16 
SZ290, h+ cdc10-v50 ura4-D18 leu1-32 ade6-M210 (a gift from Greg Freyer; (23)); (ii) SK08, h- 17 
cdc10-v50 cdc25::ura4+ ura4-D18 adh:cdc25+ ade? (23); (iii) SK12, h+ cdc10-v50 ura4-D18 18 
cds1::ura4+ leu1-32 ade? (this study). YES medium was used to grow cells, and it consisted of 19 
0.5% Yeast Extract (Difco), 3.0% glucose, 75 mg/l each of adenine, histidine and uracil, and 200 20 
mg/l of leucine. All supplements were from Sigma. Cells were grown at 25°C unless otherwise 21 
mentioned. Where indicated, MMS (Sigma) was added to a final concentration of 0.015%. 22 
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 7 
 Culture synchronization and sample collection for flow cytometry and 2D-gel 1 
analyses. For synchronization in and release from G1 phase, we used the cdc10-v50 block-and-2 
release procedure, as described here. Cells from a two-liter log-phase culture (0.8-1.0?107 3 
cells/ml) were harvested and resuspended in the same volume of fresh medium maintained at 4 
35°C. They were incubated at this temperature with vigorous shaking for different amounts of 5 
time depending upon their genotype. The cdc10-v50 cells required 4.5 hours, cdc10-v50 cds1? 6 
cells needed 4.0 hours, while cdc10-v50 cdc25OP cells required 3.5 hours at 35°C to efficiently 7 
arrest in G1. Arrested cultures were spun down; cell pellets were washed with water and divided 8 
into two parts. Half the cells were added to 1.5 liters of fresh medium (maintained at 25°C) 9 
containing no MMS. The other half of the cells were added to the same amount of fresh medium 10 
and treated with 0.015% MMS. The cultures were incubated at 25°C with vigorous shaking. At 11 
the indicated times 300 ?l and 200 ml of culture volume were removed. The 300 ?l of culture 12 
were fixed by mixing with 900 ?l of ethanol in a microfuge tube. The 200 ml sample was mixed 13 
with 0.01% sodium azide (final) and 50 mM EDTA (final) and immediately chilled on ice. 14 
Samples thus collected were kept on ice in a cold room until the completion of the experiment. 15 
Afterwards, the small samples in microfuge tubes were processed for flow cytometry as 16 
described (21, 23, 28). Cells were harvested from the larger samples, washed with ice-cold water 17 
and pelleted again. Finally, the cell pellets were kept frozen at -80°C until being used for DNA 18 
isolation. 19 
 DNA isolation and 2D-gel electrophoresis. DNA was isolated and processed for 2D-gel 20 
electrophoresis as described (16) except that BND-cellulose enrichment was omitted. For these 21 
experiments, 5 ?g of each DNA sample were digested with 5-fold excess of HindIII (New 22 
England Biolabs). The 2D gels were run as described previously (5). The DNA isolation and 23 
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 8 
general experimental procedures involved in 2D-gel analysis have also been described at our 1 
website: http://hosted2.roswellpark.org/huberman/2D_Gel_Docs_HTML.html. 2 
 Hybridization probes, re-probing, autoradiography and image processing. Probes 3 
for the centromeric K(dg) repeats,  ars2-2 and telomere-associated sequences (TAS) were 4 
described previously (21). Each 2D gel (representing a single time point from a single strain) was 5 
blotted to a GeneScreen Plus (NEN) nylon membrane, then hybridized sequentially with these 6 
three probes in the order (i) ars2-2, (ii) centromere, and (iii) telomere. The probe from each 7 
earlier hybridization was stripped from the membrane prior to subsequent hybridization by a 8 
modification of the manufacturer’s recommended protocol: the membranes were immersed in 9 
stripping buffer and heated to near boiling in a microwave oven, rather than by being boiled for 10 
10-30 minutes. This milder procedure proved sufficient for our purposes, and it reduced loss of 11 
target DNA from the membrane. The autoradiograms were captured as 16-bit TIFF images using 12 
a Molecular Dynamics Typhoon 8600 phosphorimager (GE Healthcare). The images were 13 
subsequently optimized for display of replication intermediates by taking the square root of all 14 
data points using IPLab 3.5 software (originally from Scanalytics.com; currently updated and 15 
sold as iVision 4.0 by BioVision Technologies). Both IPLab 3.5 and Photoshop (Adobe) were 16 
used to set upper and lower display limits. Except for normalization to make the signals for 1N 17 
spots the same for each 2D-gel picture in a single time course, identical operations were 18 
performed on all pictures in a single time course. 19 
 Quantitation of replication intermediates. IPLab 3.5 software (see above) was 20 
employed for quantitation of replication intermediates. Quantitation was carried out on the raw 21 
phosphorimager data files, prior to taking square roots. For each 2D gel, a segment boundary was 22 
drawn around the 1N spot(s), and the signals for all pixels inside the boundary were summed. 23 
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The total was the 1N-Spot(s) Intensity. There was no need to determine background for the 1N 1 
spot(s), because background was negligible compared to signal. Then a segment boundary was 2 
drawn around the area containing the replication intermediates (both Y and bubble arcs), with 3 
care to exclude signals from the 1N spot or from the arc of linear molecules. The segment 4 
boundary for replication intermediates was then copied and moved to a nearby portion of the gel 5 
that was judged to be signal-free and to have about the same amount of background as the 6 
replication-intermediate area. Signals from pixels within each of these two identically shaped 7 
segment boundaries were then separately summed, and their difference provided the RI Intensity. 8 
Finally, the ratio of the RI Intensity to the 1N-Spot(s) Intensity was calculated using Microsoft 9 
Excel. These ratios (in units of 10-3) are indicated in the upper left or lower right corner of each 10 
2D gel panel in Figs. 2-5. The measurements employed for these calculations may be obtained in 11 
spreadsheet format from either of the two authors. 12 
 13 
RESULTS 14 
 Dependence of the MMS-induced S-phase damage checkpoint on Cds1 and on 15 
inhibition of Cdc25 in cdc10-synchronized cells. For these experiments we used three fission 16 
yeast strains: wild type, cds1?, and a strain over-producing the Cdc25 protein, which we call 17 
cdc25OP (23). All three strains were in the cdc10-v50 background. Use of the cdc10-v50 18 
mutation permitted the cells to be synchronized by arrest in G1 at restrictive temperature (35°C), 19 
followed by release into the cell cycle at permissive temperature (25°C) (23). The cds1? cells are 20 
completely defective in the S-phase damage checkpoint, and the cdc25OP cells (which 21 
overproduce the Cdc25 protein) are also largely deficient in this checkpoint (23, 26, 28). After 22 
synchronization by G1 arrest at 35°C and release at 25°C, we followed the cells’ progression into 23 
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 10
and through S phase by collecting samples for flow cytometry. We also collected larger samples 1 
for 2D-gel analyses in parallel as described in Materials and Methods. All experiments were 2 
performed twice, with essentially identical results. 3 
 Fig. 1 shows the flow cytometry profiles for the three strains. In the absence of MMS, 4 
most cdc10-v50 (wild-type) cells completed S phase by 150 minutes (Fig. 1A “?” panel). 5 
Progression through S phase was slower in MMS-treated wild-type cells (Fig. 1A “MMS” 6 
panel). A significant fraction of these cells was still in S phase at 150 minutes. In contrast, as 7 
shown in Fig. 1B and 1C, the flow cytometry profiles of untreated and MMS-treated cds1? and 8 
cdc25OP cells were nearly identical, regardless of MMS treatment. Thus, the MMS-induced 9 
slowing of S phase evident in the wild-type cells depended on the checkpoint kinase, Cds1, and 10 
could be suppressed by overexpression of the Cdc25 phosphatase, as previously observed (23). 11 
 Effects of MMS treatment on replication in wild-type cells. We carried out 2D-gel 12 
analyses for the samples shown in Fig. 1. We chose to analyze the replication timings of three 13 
regions—centromeres, telomeres, and ars2-2—whose replication timings in wild-type cells, in 14 
the absence of MMS, have previously been well studied. Centromeres normally replicate in very 15 
early S phase, ars2-2 is normally passively replicated in middle or late S phase, and telomeres 16 
normally replicate in late S phase (20, 21). In our previous work (20, 21) and here, we analyzed 17 
HindIII restriction fragments containing either a repeated segment of centromeric DNA with a 18 
potential origin, a repeated segment of telomeric DNA with a potential origin, or a segment of 19 
unique DNA containing the potential origin, ars2-2. Because we studied only HindIII restriction 20 
fragments, we needed to digest the DNA from each strain and time point only with HindIII, and 21 
we could analyze all of that DNA in a single 2D gel. Then we were able to probe the single 22 
nylon membrane, that resulted from blotting each 2D gel, sequentially with probes corresponding 23 
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 11
to ars2-2, centromeres, and telomeres. In this way, each probing served as a control for the other 1 
probings of the same membrane. In addition, our use of repeated sequences enabled us obtain 2 
stronger and more easily interpretable RI signals in those cases. 3 
 Fig. 2 shows the replication patterns in wild-type cells of HindIII restriction fragments 4 
containing centromeric K(dg) repeats or ars2-2 (a unique locus on chromosome 2). In Fig. 2 and 5 
subsequent figures, in all samples, the main signal appears as a large spot or spots (black area(s) 6 
in the lower left corner, called the “1N spot(s)”), which represent(s) the linear non-replicating 7 
restriction fragment(s). In the case of the K(dg) repeats shown in Fig. 2A, digestion with HindIII 8 
gave rise to 4.3-kb fragments from the centromere of chromosome 2 and 3.3-kb fragments from 9 
the centromeres of chromosomes 1 and 3. Thus there are two 1N spots in each panel of Fig. 2A. 10 
Replication intermediates (RIs) generate two arc-shaped signals. A high-rising “bubble-arc” 11 
signal (example in Fig. 2A) is generated when a restriction fragment contains a functional 12 
replication origin in its central third. The family of RIs containing different sizes of internal 13 
bubbles collectively produces the bubble-arc signal. In contrast, a “Y-arc” signal (example in 14 
Fig. 2A) is produced by the family of Y-shaped RIs generated by a single replication fork 15 
traversing the region (5). 16 
 There is a weak Y-arc signal in the 0-minute time point in Fig. 2A and in many of the 17 
other figures (3A, 4A, 5B, 5C). This seems to be due to imperfect synchrony. A few cells appear 18 
to enter S phase even at 35°C, and in this small population of cells RIs are generated in early-19 
replicating regions such as the K(dg) repeats. 20 
 Like most replication origins in fission yeast (10, 13, 15, 32, 35), the origins within the 21 
centromeric K(dg) repeats fire with low efficiency, so most of the HindIII restriction fragments 22 
from the K(dg) repeats are passively replicated by forks from origins in nearby, flanking 23 
ACC
EPT
ED
 at CALIFO
RNIA INSTITUTE O
F TECHNO
LO
G
Y on Decem
ber 1, 2008 
m
cb.asm
.org
D
ow
nloaded from
 
 12
fragments. These generate Y arcs. Only a minority of restriction fragments contain active origins 1 
and generate bubble arcs (21). When averaged over the whole population, the result is a mixed 2 
pattern, with a strong Y arc and a weak bubble arc (Fig. 2A). The low ratio of bubble arcs to Y 3 
arcs is due to origin inefficiency, not to breakage of bubble arcs during DNA preparation, 4 
because broken bubbles do not produce the true Y arc signals observed here (18). Because the 5 
passively replicated fragments are always close to fragments with active origins, which fire at 6 
about the same time, the relative abundances of Y arc signals and bubble arc signals remain 7 
roughly constant during the time course (Fig. 2A). We use the total abundance of signals from all 8 
RIs, both bubble arcs and Y arcs, to determine replication timing (21). We quantitated these 9 
signals by determining the ratios of signals from RIs to signals from 1N spot(s), and we show 10 
these ratios (in units of 10-3) in the lower right corners of the panels in Fig. 2 (note: the ratios are 11 
shown in the upper left corners of the panels in Figs. 3-5). 12 
 In the absence of MMS, RIs from the early-replicating K(dg) repeats were primarily 13 
observed at 30 and 60 minutes post-release, consistent with the previously described early 14 
replication of K(dg) repeats (20, 21). In the MMS-treated samples, low concentrations of RIs 15 
were present at 30 and 60 minutes, but there was a major accumulation of RIs at 90 minutes. 16 
Thus, upon MMS treatment in these cells, in most cases replication of K(dg) repeats was delayed 17 
by at least 30 minutes. Additionally, RIs were still present at the 150-minute time point in MMS-18 
treated cells, whereas they were reduced to background level by 120 minutes in untreated cells 19 
(the stronger signal at 150 minutes may be due to some cells entering the next cell cycle and 20 
beginning to replicate centromeres, which normally replicate very early). Notice that RIs persist 21 
in MMS-treated cells for a longer time (60 minutes) past the peak of origin firing at 90 minutes 22 
than they do in wild-type cells (only 30 minutes) past the peak of origin firing at 60 minutes. 23 
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 13
This relative persistence of RIs in the MMS-treated cells is consistent with slowing of replication 1 
forks in these cells. These results suggest that retardation of DNA synthesis in the vicinity of 2 
centromeres upon MMS treatment in checkpoint-competent cells may be a composite of delay in 3 
firing of a large proportion of origins within K(dg) repeats and reduction in the rate of 4 
replication-fork movement through these repeats. 5 
 In contrast to the K(dg) repeats, which generate HindIII restriction fragments of two 6 
different sizes, ars2-2, which is a unique sequence located on the right arm of chromosome 2, 7 
generates a single 1N spot (Fig. 2B). The ars2-2 sequence is usually replicated passively in 8 
middle to late S phase by replication forks arising from earlier-firing, flanking origins (21). In 9 
other words, ars2-2 is an even less efficient origin than the origins in the K(dg) repeats. In Fig. 10 
2B, consistent with previous observations, the ars2-2 RIs from untreated cells appeared at 60 11 
minutes and peaked at 90 minutes in middle to late S phase. In contrast, RIs from the MMS-12 
treated cells appeared at 60 minutes but then persisted with increasing intensities through the 13 
time course. The most intense ars2-2 RIs were detected at 150 minutes. These observations are 14 
consistent with the observed slowing of S phase in MMS-treated wild-type cells (Fig. 1A), but 15 
they do not distinguish between (i) retardation of the origins responsible for replicating ars2-2, 16 
(ii) slowing of the replication forks that travel from those origins to ars2-2, or (iii) a combination 17 
of these. Nevertheless, the results obtained with ars2-2 in wild-type cells (Fig. 2B) provide an 18 
interesting comparison to results obtained in cds1? (Fig. 3B) and cdc25OP (Fig. 4B) cells. 19 
 No major effect of MMS treatment on replication in cds1  cells. As shown in the “? 20 
MMS” panel of Fig. 3A, the RIs from K(dg) repeats in the cds1? cells were most intense in the 21 
30-, 60- and 90-min samples, and they lost intensity in later time points, similar to untreated 22 
checkpoint-competent cells. This replication timing profile remained essentially unaltered upon 23 
ACC
EPT
ED
 at CALIFO
RNIA INSTITUTE O
F TECHNO
LO
G
Y on Decem
ber 1, 2008 
m
cb.asm
.org
D
ow
nloaded from
 
 14
MMS treatment, consistent with the lack of effect of MMS treatment on the rate of passage 1 
through S phase in cds1? cells (Fig. 1B). In both the absence and presence of MMS, the signals 2 
from bubble arcs were significantly lower relative to Y arcs than for checkpoint-competent cells 3 
(Fig. 2A) or for cdc25OP cells (Fig. 4A). This observation suggests that Cds1 may be needed for 4 
optimum replication origin efficiency, at least under these synchronization conditions, in both the 5 
absence and presence of MMS. 6 
 Our comparison of the replication profiles of ars2-2 in cds1? cells led to a similar 7 
conclusion (Fig. 3B). Neither the time of replication (primarily 90-120 minutes in late S phase) 8 
nor the longevities of the RIs were significantly altered by MMS treatment. Thus, Cds1 is 9 
required both to delay the firing of replication origins in the K(dg) repeats and to delay the 10 
replication of ars2-2 in MMS-treated cells. Cds1 is also required for the persistence of RIs seen 11 
in MMS-treated checkpoint-competent cells (compare Figs. 2 and 3), which suggests that Cds1 12 
may be required to slow replication forks after DNA damage. 13 
 No major effect of MMS treatment on replication in Cdc25-overexpressing cells. We 14 
recently demonstrated that, under our experimental conditions, the Cdc25-Cdc2 pathway 15 
operating downstream of Cds1 is primarily responsible for MMS-induced slowing of S phase 16 
(23). We wanted to know if the same pathway was responsible for inhibiting replication origins 17 
and/or replication-fork movement upon DNA damage. To test this, we employed a fission yeast 18 
strain overproducing Cdc25, which had been shown to have reduced phosphorylation at the Tyr-19 
15 residue of Cdc2 (12), leading to Cdc2 hyperactivity. Fig. 1C shows flow cytometry profiles of 20 
G1-synchronized, untreated and MMS-treated cdc25OP cells. The rate of passage through S 21 
phase in these cells was not reduced by MMS treatment. Hence, these cells, like the cds1? cells, 22 
are deficient in the S-phase damage checkpoint.  23 
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 15
 In contrast to wild-type cells (Fig. 2A), but similar to cds1? cells (Fig. 3A), MMS 1 
treatment did not reduce the rate of replication of the K(dg) repeats in cdc25OP cells (Fig. 4A). 2 
Indeed, replication of the K(dg) repeats was in fact somewhat faster in MMS-treated cdc25OP 3 
cells than in untreated cells. We do not know why MMS treatment accelerated replication of the 4 
K(dg) repeats in these cells. It is also interesting that the bubble arc signals in Fig. 4A (cdc25OP 5 
cells) are as strong as those in Fig. 2A (wild-type cells), while the bubble arc signals in Fig. 3A 6 
(cds1? cells) are much weaker. The reasons for this observation are not clear, but the relatively 7 
strong bubble arcs generated by the cdc25OP cells (Fig. 4A) could be a result of hyperactive 8 
Cdc2 leading to increased origin efficiencies. 9 
 In Fig. 4B, the most intense ars2-2 RIs appeared at 90 minutes (untreated and MMS-10 
treated), and the intensities of the RIs at later times appeared similar in the untreated and MMS-11 
treated cells. Thus, MMS treatment failed to delay the replication of these regions and failed to 12 
prolong the existence of RIs when Cdc25 was overexpressed. The same defects in the S-phase 13 
checkpoint response to MMS-induced DNA damage were evident in the cdc25OP cells (Fig. 4) 14 
as in the cds1? cells (Fig. 3). 15 
 Effects of DNA damage on replication of telomeres. In budding and fission yeasts, 16 
telomere regions contain late-firing origins and usually replicate in late S phase (21, 38). Fig. 5 17 
shows 2D-gel analyses of the four terminal HindIII restriction fragments from the ends of 18 
chromosomes 1 and 2. These fragments were detected with a  “telomere-associated sequence” 19 
(TAS) probe that had previously been used in our laboratory for studies of telomere replication 20 
timing (21). These fragments contain potential replication origins that sometimes generate 21 
detectable bubble arcs, but usually only Y arcs are visible (21). When these fragments are 22 
passively replicated, the origins responsible for their replication must be a subset of the 23 
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numerous potential origins found near fission yeast telomeres (13, 32). As in the case of the 1 
K(dg) repeats, the bubble- and Y-arc signals from telomeres display identical kinetics of 2 
appearance and disappearance, so we use the total amount of RIs at each time point as a measure 3 
of replication timing (21). In the experiments presented here, only Y arcs were visible (Fig. 5). 4 
These Y arcs appear unusual for two reasons. First, the detected HindIII restriction fragments are 5 
large (about 8 kb), leading to distorted Y arcs under the standard gel electrophoresis conditions 6 
employed here (17). Second, the TAS probe detects HindIII fragments of four different sizes 7 
from the total of four ends of chromosome 1 and 2, so multiple, usually overlapping, 1N spots 8 
and Y arcs are detected. 9 
 In the absence of MMS, the telomeric RIs in checkpoint-competent cdc10-v50 cells were 10 
most intense at 60 and 90 minutes, with reduced intensities at later times (Fig. 5A). In these cells, 11 
telomeres replicated in middle S phase (note that 60-90 minutes corresponds to middle S phase; 12 
Fig. 1A) in contrast to previously studied cell lines, where telomeres replicated in late S phase 13 
(21). Interestingly, the appearance of telomeric RIs was not delayed by MMS treatment, but, in 14 
MMS-treated cells, the RIs persisted for longer times—the RI intensities at 90, 120 and 150 min 15 
were higher in the MMS-treated cells than in the untreated cells. Thus, the time of telomere 16 
replication was not delayed, but it was prolonged by MMS treatment, consistent with reduced 17 
rate of fork movement. 18 
 In cds1? cells (Fig. 5B), in the absence of MMS, the most intense RIs appeared at 60 19 
minutes, but a low intensity RI signal was visible all through the time course, indicating a 20 
reduced synchrony of telomere replication in these cells. Surprisingly, telomere replication 21 
synchrony was further reduced in MMS-treated cds1? cells, with almost constant RI signals 22 
from 30 min to 120 min. 23 
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 In cdc25OP cells (Fig. 5C), these effects were exacerbated. In these cells, even in the 1 
absence of MMS, telomere replication synchrony was significantly reduced, and the time of 2 
maximum RI signal strength was delayed until 90–150 minutes. MMS treatment did not produce 3 
any noticeable change in the RI pattern. In this strain, one of the HindIII fragments detected by 4 
the TAS probe was significantly larger than the others, and this larger fragment produced a Y arc 5 
that was more angular than the arcs generated by the other fragments (as predicted on the basis 6 
of the study by Hyrien and Mechali (17)). 7 
 The fact that a Y-arc signal was present at the 0-minute time point in Figs. 5B and 5C but 8 
not 5A is probably a consequence of the loss of replication timing control in the cds1? and 9 
cdc25OP cells. In these cells, replication of telomeres appeared to begin in early S phase and 10 
then continue through the rest of S phase. RIs from early-replicating regions, including 11 
telomeres, would be expected to be present at the 0-minute time point in the portion of cells that 12 
escaped synchrony and entered S phase during the 35°C temperature block. Note that a Y-arc 13 
signal was also generated by a portion of these cells at the 0-minute time point for the early-14 
replicating K(dg) repeats (Figs. 3A, 4A) but not for the later-replicating ars2-2 (Figs. 3B, 4B). 15 
 16 
DISCUSSION 17 
 Here we have reported the results of measurements of the abundances of replication 18 
intermediates (RIs) from centromeres, telomeres, and ars2-2 (a unique region on chromosome 2) 19 
during the course of synchronized S phase in wild-type and checkpoint-mutant fission yeast 20 
cells, treated or not with the DNA-damaging agent, MMS. These results lead to three surprising 21 
conclusions, which are explained in the following three sections of the Discussion. 22 
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 The checkpoint response to MMS is different from the checkpoint response to 1 
hydroxyurea (HU). Previous studies indicated that fission yeast checkpoint responses to both 2 
MMS (which methylates DNA) and HU (which slows replication forks by inhibiting the 3 
synthesis of dNTPs) are mediated in part by the same pathway—a pathway involving the 4 
upstream checkpoint kinase Rad3, the downstream checkpoint kinase Cds1, the phosphatase 5 
Cdc25, and the cyclin-dependent kinase Cdc2 (Rad3 ? Cds1  Cdc25 ? Cdc2; see 6 
Introduction) (4, 11, 21, 23, 24, 26, 28, 40). The results presented here show that, although 7 
fission yeast checkpoint responses to MMS and HU do, indeed, make use of these proteins, there 8 
must be other components of the cellular responses to MMS and HU that distinguish between 9 
MMS and HU, because the final results of checkpoint activation appear to be quite different in 10 
the two cases. 11 
 HU slows replication forks by inhibiting ribonucleotide reductase, which deprives DNA 12 
polymerases of their substrates, the deoxyribonucleoside triphosphates. In response to HU 13 
treatment, fission yeast cells activate Rad3 and Cds1, and this leads to inhibition of Cdc25. Since 14 
Cdc25 is an activator of Cdc2, this results in the inhibition of Cdc2 and prevention of mitosis due 15 
to lack of active Cdc2 (40). In addition, HU-treated fission yeast cells delay the firing of 16 
replication origins located near ars2-2 and telomeres (both of which normally replicate in middle 17 
to late S phase), and this delay is dependent on Rad3 and Cds1 (13, 15, 21, 32). However, it is 18 
not known whether this delay is also dependent on inhibition of Cdc25 and Cdc2. In contrast, the 19 
firing of early replication origins in the presence of HU is unaffected by the checkpoint proteins 20 
Rad3 and Cds1 (13, 15, 21, 32). 21 
 When we initiated this 2D gel analysis of origin firing in MMS-treated fission yeast cells, 22 
we anticipated that we would obtain results similar to those previously obtained with HU (no 23 
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effect on early origins, inhibition of late origins). Instead, we found that the firing of a significant 1 
portion of the early-firing origins located in the K(dg) repeats of centromeres is delayed, in 2 
checkpoint-dependent fashion, by MMS treatment (Figs. 2A, 3A and 4A). We also found that, in 3 
wild-type fission yeast cells, telomeres replicated at their normal middle- to late-S times 4 
regardless of the presence of MMS (Fig. 5A). The replication of ars2-2 (which normally 5 
replicates in middle to late S phase) was delayed, in checkpoint-dependent fashion, by MMS 6 
treatment, but this may have been an effect of checkpoint-dependent retardation of replication 7 
fork movement (see below) rather than inhibition of origin firing, since ars2-2 was replicated by 8 
forks from flanking origins under the conditions employed here. Thus, at least for two of the 9 
three regions that we studied, the effects of MMS treatment in fission yeast cells seem opposite 10 
to those of HU treatment: the early centromere origins are unaffected by HU (13, 15, 21, 32) but 11 
are partially delayed by MMS, whereas the later-firing telomere origins are delayed by HU (13, 12 
21, 32) but are unaffected by MMS. 13 
 Furthermore, our finding that the MMS-induced inhibition of centromeric origins is 14 
dependent both on Cds1 and on normal levels of Cdc25 (Figs. 3A and 4A) suggests that this 15 
inhibition is mediated by the same Rad3 ? Cds1  Cdc25 ? Cdc2 pathway that is also 16 
activated by HU treatment. In HU-treated cells, this pathway leads to inhibition of mitosis but is 17 
not known to affect origin firing. In contrast, in MMS-treated cells, our results suggest that this 18 
pathway affects the firing of centromeric origins (and perhaps other early origins), but the 19 
pathway is not known to affect entry into mitosis (note: MMS-treated cells do arrest in G2, prior 20 
to entry into mitosis, but the arrest is dependent on Chk1, not Cds1 (47)). We conclude that 21 
additional pathways, that differ between MMS and HU, must be activated in MMS- and/or HU-22 
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treated cells, and these additional pathways must mediate the different effects of checkpoint 1 
activation on origin firing in MMS- and HU-treated cells. 2 
 The checkpoint response to MMS leads to inhibition of early-firing origins at 3 
centromeres but not late-firing origins at telomeres. As indicated above, this result was 4 
unanticipated, because it is quite different from what had previously been found in HU-treated 5 
fission yeast cells (21) or in HU- or MMS-treated budding yeast cells (41, 45). However, 6 
inhibition of early origin firing was previously observed in mammalian cells in response to DNA 7 
damage by ionizing radiation and by MMS (25, 31), so we should not have been surprised to find 8 
it in fission yeast. Furthermore, our laboratory has recently found that, in fission yeast cells 9 
bearing mutations in the genes encoding either of the histone deacetylases, Clr3 or Clr6, early-10 
firing origins are partially delayed while late-firing origins are unaffected (S. Ramanathan, R. M. 11 
Givens, A. Chaudari, G. Jahreis and J. A. Huberman, manuscript in preparation). Since the 12 
effects of these histone deacetylase mutations are similar to the effects of MMS treatment of 13 
checkpoint-competent cells, it is possible that MMS-induced inhibition of early origin firing 14 
could be mediated in part by modulation of the acetylation levels of histones (or other proteins, 15 
since both Clr3 and Clr6 are probably capable of de-acetylating some non-histone proteins). 16 
 The checkpoint response to MMS appears to include inhibition of replication fork 17 
movement. The overall rate of passage through S phase is reduced in MMS-treated, checkpoint-18 
competent cells (Fig. 1A). It is uncertain whether partial retardation of early centromeric 19 
replication origin firing (Fig. 2A) and, perhaps, retardation of the firing of other origins are 20 
sufficient to account for the overall slowing of S phase. An alternative mechanism that could also 21 
contribute to slowing of S phase is reduction in rate of fork movement. Indeed, the observed 22 
persistence of RIs in MMS-treated, checkpoint-competent cells (Figs. 2, 5A) can most easily be 23 
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explained by reduced fork speed. Another possible alternative explanation for the persistence of 1 
RIs would be spreading the firing of origins over a longer time span, as seen for the origins in the 2 
centromeric K(dg) repeats in MMS-treated checkpoint-competent cells (Fig. 2A); this should 3 
lead to an equivalent increase in RI persistence without requiring a reduction in fork speed. 4 
Although staggering the firing of origins may contribute to the observed persistence of RIs, we 5 
think that reduced rate of fork movement is a more important contributor for the following 6 
reasons. First, the relative abundance of RIs at later time points is higher in MMS-treated wild-7 
type cells than in untreated cells, consistent with the fact that slow-moving replication forks 8 
require a greater portion of the cell cycle to replicate a restriction fragment. Thus RIs will always 9 
be more abundant in restriction fragments that are replicated by slow-moving forks. Second, in 10 
contrast, staggered origin firing would spread the signal from RIs over more time points, thus 11 
diluting the abundance of RIs at any given time point, which is not observed. Third, the time 12 
span over which centromeric RIs persist is longer than the delay in origin firing (Fig. 2A). 13 
Fourth, RIs persist even in the case of telomeres, for which no initial delay in origin firing is 14 
evident (Fig. 5A). Future investigations using microarray or DNA fiber fluorography techniques 15 
will be able to provide more precise characterization of the S-phase damage checkpoint effect on 16 
fork speed. 17 
 The mechanism by which replication forks might be slowed during S-phase damage 18 
checkpoint responses is not yet clear. The mechanism might involve uniform reduction in fork 19 
speed, or it might involve a combination of normal fork speed in undamaged regions with 20 
reduced fork speed, even complete fork stalling, in regions containing still-unrepaired damage. 21 
Several proteins in fission yeast both contribute to replication fork stabilization and participate in 22 
S-phase checkpoints. In some cases these proteins also bind directly to replication forks. These 23 
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proteins include Mrc1, Swi1, Swi3, Tel2 and the Dfp1-Hsk1 kinase (1, 30, 33, 43, 46, 47, 50-52). 1 
Since these proteins contribute to fork stability, it seems likely that they may also be involved in 2 
slowing forks in cells with damaged DNA. Indeed, Tim and Tipin, the mammalian homologues 3 
of Swi1 and Swi3, are important for inhibiting replication fork movement after DNA damage by 4 
ultraviolet light (54). The hypothesis that proteins involved in maintenance of replication fork 5 
stability and/or in bypass of DNA lesions might be responsible for checkpoint-dependent 6 
damage-induced slowing of replication fork movement in fission yeast was previously proposed 7 
by Rhind and Russell (39). So far as we are aware, the persistence of RIs noted in this study 8 
(Figs. 2A, 5A) is the first experimental evidence supporting this hypothesis. 9 
 The fact that both persistence of RIs (which is evidence for fork slowing) and slowing of 10 
passage through S phase are abolished in cells over-producing the Cdc25 protein (Figs. 1C, 4, 11 
and 5C) implies that the Cdc25 protein and its target, the Cdc2 cyclin-dependent kinase, are 12 
likely to be involved in the mechanism of fork slowing. The activities of any of the above-13 
mentioned proteins (Mrc1, Swi1, Swi3, Tel2 and Dfp1-Hsk1) might be modulated (directly or 14 
indirectly) by Cdc2. Another means by which Cdc2 might regulate fork movement is provided 15 
by the example of the mammalian cyclin-dependent kinase, Cdk2, which phosphorylates several 16 
Mcm proteins (29). This phosphorylation may regulate the helicase activity of the Mcm complex 17 
and thus may regulate the rate of replication-fork movement. Cdk2 also plays a role in chromatin 18 
decondensation during S phase (2). If chromatin decondensation is rate-limiting for replication-19 
fork movement, then regulation of chromatin structure would provide another method by which 20 
Cdk2 in mammalian cells or Cdc2 in fission yeast could regulate replication fork rate. 21 
 The MMS-induced slowing of replication forks in budding yeast cells was reported to be 22 
checkpoint-independent (53). However, this may depend on the concentration of MMS 23 
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employed. We have found that, in fission yeast cells, a higher concentration (0.03%) of MMS 1 
frequently leads to checkpoint-independent S-phase slowing (Kumar, S. and Huberman J.A., 2 
unpublished observations). In addition, Szyjka et al. (49) recently found that Rad53 (the 3 
homologue of Cds1) slowed replication forks in MMS-treated budding yeast cells, presumably in 4 
order to stabilize them. Resumption of fork progression required inactivation of Rad53. The 5 
authors speculate that the apparent checkpoint-independence of the previously observed (53) 6 
MMS-induced replication fork slowing might have been the consequence of  a fortuitous balance 7 
between the fork-slowing effect of increased fork damage in rad53? cells and the fork-8 
accelerating effect of loss of Rad53 in those cells. 9 
 Although checkpoint-mediated replication fork slowing is still controversial in budding 10 
yeast, there is accumulating evidence for its occurrence in mammalian cells. In two independent 11 
investigations, Chk1-mediated responses to DNA breaks near replication forks led to significant 12 
reductions in fork progression rates (42, 44), and in UV-treated mammalian cells, the Chk1-13 
dependent checkpoint was activated and replication forks were slowed in a process requiring the 14 
fork-protection proteins, Tim and Tipin (54). Thus, combined observations in fission yeast, 15 
budding yeast, and mammalian cells suggest that checkpoint-dependent replication fork slowing 16 
is probably an evolutionarily conserved phenomenon. 17 
 The Cdc25 phosphatase is an important mediator of the S-phase damage checkpoint 18 
response to low levels of MMS. Like the results in this paper (Figs. 1, 4, 5C), our earlier 19 
observations (23) also suggested that the S-phase damage checkpoint response to low levels of 20 
MMS involves inhibition of Cdc25 activity, with consequent failure to activate Cdc2. 21 
Kommajosyula and Rhind (22) were unable to reproduce our earlier observations and questioned 22 
whether Cdc25 and Cdc2 are important for the checkpoint response to MMS treatment during S 23 
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phase. However, some of their experiments were carried out at 0.03% MMS, which is twice as 1 
high as the highest concentration employed by us (0.015%). Furthermore, the effective 2 
concentration of the batch of MMS employed by Kommajosyula and Rhind (22) may have been 3 
greater than the effective concentration of the batch employed by us, for the following reasons. 4 
First, we have observed considerable batch-to-batch variation in effective concentrations of 5 
MMS, as judged by the concentration required to produce a given biological effect (which, in our 6 
case, is the retardation of progression through S phase in wild-type cells). Second, the Rhind 7 
laboratory has reported that, under their conditions, the MRN complex was required for the 8 
checkpoint response to MMS treatment (6). Under our conditions, however, deletions of 9 
components of the MRN complex had no effect on the checkpoint ((28); Kumar, S. and 10 
Huberman, J.A., unpublished). In mammalian cells and budding yeast, the MRN complex is 11 
required for responses to a specific kind of DNA damage—double-strand breaks (reviewed in 12 
(48))—and formation of double-strand breaks is likely to occur primarily at higher MMS 13 
concentrations, since MMS itself simply methylates DNA. Third, the magnitude of inhibition of 14 
progression through S phase was consistently higher in the studies of Kommajosyula and Rhind 15 
(22) than in our experiments, even for experiments carried out at the same nominal MMS 16 
concentrations. Finally, Kommajosyula and Rhind (22) did not test the effect of deleting the cds1 17 
gene on MMS-induced S-phase slowing; they only tested deletion of the rad3 gene. But Rad3 is 18 
needed to activate both the Chk1 kinase and the Cds1 kinase. Thus it is possible that the 19 
checkpoint-dependence of MMS-induced S-phase slowing studied by Kommajosyula and Rhind 20 
(22) reflected a damage-checkpoint pathway mediated by Chk1 rather than an S-phase pathway 21 
mediated by Cds1. In our hands, Cds1 but not Chk1 was required for the checkpoint response to 22 
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low levels of MMS (28), and we have observed that higher levels of MMS lead to Cds1-1 
independent slowing of S phase (Kumar, S., and Huberman, J.A., unpublished). 2 
 Kommajosyula and Rhind (22) suspected that, in our earlier studies of the importance of 3 
Cdc25 for the S-phase checkpoint response to MMS (23), we may have been misled by our use 4 
of whole-cell flow cytometry rather than nuclear flow cytometry. However, the 2D gel results 5 
presented in this paper (Figs. 4 and 5C) are completely independent of flow cytometry method. 6 
Instead, the abundance of RIs at each time point is a direct measure of the amount of DNA 7 
replication taking place within the detected restriction fragment at that time point. These results 8 
show clearly that cells overproducing the Cdc25 phosphatase are unable to slow replication when 9 
treated with the low level of MMS employed in our studies. In contrast, at the same level of 10 
MMS, wild-type cells are able to slow S phase (Figs. 2, 4, 5A and 5C). 11 
 For these reasons, we suspect that fission yeast cells may employ (at least) two different 12 
pathways in their checkpoint responses to MMS damage during S phase. When MMS damage is 13 
minimal, and few or no double-strand breaks are generated, both Cdc25 and Cdc2 are important 14 
downstream components of the checkpoint response ((23); this paper). However, when MMS 15 
damage is extensive enough to generate double-strand breaks, the MRN complex may mediate a 16 
stronger response that overwhelms the response involving Cdc25 and Cdc2 (6, 22). The 17 
involvement of two response pathways to MMS damage in fission yeast is reminiscent of the two 18 
pathways responding to UVC damage in mammalian cells: one pathway involving ATR, Chk1, 19 
and Dbf4 responds to low levels of UVC, while a second pathway involving ATM, ATR, and the 20 
MRN complex responds to higher levels (14, 34). 21 
 Loss of telomere replication synchrony in checkpoint-mutant cells. In the absence of 22 
MMS, we observed that the temporal replication patterns of the K(dg) repeats and the ars2-2 23 
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region were similar in wild-type and checkpoint-mutant cells (Figs. 2-4). In all cases, the K(dg) 1 
repeats replicated before ars2-2, with their replication timing roughly 30 minutes apart. This 2 
conservation of replication timing in untreated checkpoint-competent and checkpoint-mutant 3 
cells for the K(dg) repeats and for ars2-2 contrasts with the loss of replication synchrony for the 4 
telomere regions in checkpoint-mutant cells (Figs. 5B, C). The contrast is more striking 5 
considering that the different results were obtained for the same 2D-gel membranes, which were 6 
hybridized, stripped, and re-hybridized until all three of the probes (ars2-2, K(dg) repeats and 7 
telomeres) had produced results (Figs. 2-5). Thus loss of telomere replication synchrony and 8 
timing occurred in the very same checkpoint-incompetent cells in which the synchrony and 9 
timing of the K(dg) repeats and ars2-2 were preserved. 10 
 The reduction in telomere replication synchrony was more severe for the cdc25OP strain 11 
than for the cds1? strain. Note that cds1? cells are thought to be defective in regulation of Cdc2 12 
activity only upon DNA damage. In contrast, the Cdc2 protein is constitutively more active in 13 
cdc25OP cells. This difference in Cdc2 regulation may underlie the differences that we observed 14 
between the replication profiles of telomeric regions in the untreated cds1? and cdc25OP cells. 15 
These results suggest that a functional checkpoint mechanism that regulates Cdc2 activity may 16 
be required to restrain the replication of telomeres even in the absence of DNA damage, at least 17 
under these experimental conditions. 18 
 Fission yeast as a model system for understanding the role of cyclin-dependent 19 
kinase activity in regulating both replication fork movement and origin firing in response 20 
to DNA damage. Involvement of Cdc25 and Cdk homologues in the S-phase damage checkpoint 21 
was first demonstrated in vertebrates. Recent studies in vertebrates indicate that this checkpoint 22 
leads to inhibition of both origin firing and replication fork movement. Similarly, our 23 
AC
EPT
ED
 at CALIFO
RNIA INSTITUTE O
F TECHNO
LO
G
Y on Decem
ber 1, 2008 
m
cb.asm
.org
D
ow
nloaded from
 
 27
experiments provide evidence for roles for Cdc2 in controlling both origin firing and rates of 1 
replication-fork movement after DNA damage. In budding yeast, where the effects of DNA 2 
damage upon DNA replication have been most extensively studied, the Cdc25 and Cdc2 3 
homologues do not appear to play any role in the DNA-damage-induced slowing of S phase. 4 
Furthermore, the firing of early origins is not affected in budding yeast (45). Thus, S. pombe 5 
could be the model system of choice for asking further questions about the targets of Cdc2 in the 6 
replication apparatus that bring about both slowing of replication forks and inhibition of early 7 
(and possibly late) replication origins when DNA is damaged. 8 
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FIGURE LEGENDS 1 
FIG. 1. Assay for the MMS-induced S-phase damage checkpoint. Cells bearing the cdc10-v50 2 
mutation were arrested in G1 by incubation at 35°C. At “0 minutes”, the cells were released into 3 
the cell cycle by reducing the temperature to 25°C. Panels labeled “MMS” were treated with 4 
0.015% MMS at 0 minutes. Samples were collected at the indicated times and analyzed by flow 5 
cytometry. (A) Wild type (cdc10-v50) cells retarded their progression through S phase when 6 
treated with MMS. (B) and (C) In contrast to wild type, cds1? (B) and cdc25OP (C) cells failed 7 
to slow their progression through S phase upon DNA damage. Because fission yeast cells 8 
become elongated when cell-cycle arrested, which affects their optical properties, the positions 9 
of 1C and 2C peaks cannot be determined from log-phase flow cytometry profiles. We 10 
determined the positions of the "1C" lines from the position of the major peak at 0 minutes, 11 
modified by the position of the major peak at 30 minutes in the case (cds1? cells; panel B) where 12 
the 30-minute peak was left of the 0-minute peak. The positions of the "2C lines were 13 
determined by the position of the rightmost of the major peaks (without and with MMS) at 150 14 
minutes. In all panels, the distance separating the 1C line from the 2C line is identical for the 15 
untreated and MMS-treated samples. That the untreated cds1? cells were indeed at the end of S 16 
phase at the 150-minute time point, despite showing a peak slightly to the left of the 2C line, is 17 
evident from the 2D gels in Figs. 3 and 5B,  where the RIs from the untreated cells were 18 
consistently at background level at 150 minutes. 19 
 20 
FIG. 2. 2D gel analyses of replication intermediates in the wild-type strain (cdc10-v50) at the 21 
indicated times after shift to 25°C. In each panel, the ratio of replication intermediates to 1N 22 
spot(s) is shown (in units of 10-3) in the lower right corner of each panel. (A) Replication profile 23 
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of K(dg) repeats. In the absence of MMS these restriction fragments were passively replicated 1 
(indicated by strong “Y arcs”) or, less frequently, were replicated by the firing of internal origins 2 
(indicated by faint “bubble arcs”). The non-replicating forms of the restriction fragments formed 3 
“1N spots”. Replication took place predominantly at 30 and 60 minutes (“?MMS” panel). MMS 4 
treatment delayed maximum replication until 90 minutes, and RIs persisted at 120 and 150 5 
minutes. (B) Replication profile of ars2-2. The restriction fragment containing ars2-2 replicated 6 
later than the K(dg) repeats in the untreated cells, and MMS treatment further delayed its 7 
replication. The abundance of RIs in MMS-treated cells increased at the later time points. 8 
 9 
FIG. 3. 2D-gel analyses of replication intermediates in the cds1? strain. In each panel, the ratio 10 
of replication intermediates to 1N spot(s) is shown (in units of 10-3) in the upper left corner of 11 
each panel. MMS treatment failed to delay the replication of either the K(dg) repeats (A) or ars2-12 
2 (B), and RIs did not persist at later time points. 13 
 14 
FIG. 4. 2D-gel analyses of replication intermediates in the cdc25OP strain. In each panel, the 15 
ratio of replication intermediates to 1N spot(s) is shown (in units of 10-3) in the upper left corner 16 
of each panel. MMS treatment had no significant effect on replication of the K(dg) repeats (A) or 17 
ars2-2 (B). The replication profiles appear similar to those in the cds1? strain (Fig. 3). 18 
 19 
FIG. 5. 2D-gel analyses of the terminal HindIII fragments at the telomeres of chromosomes 1 20 
and 2 in untreated and MMS-treated cells. In each panel, the ratio of replication intermediates to 21 
1N spot(s) is shown (in units of 10-3) in the upper left corner of each panel. (A) Wild type cells 22 
prolonged their replication of telomeres upon MMS treatment, and the RIs from these regions 23 
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persisted at later time points. (B) and (C) Replication of telomeres in cds1? (B) and cdc25OP 1 
(C) cells was not confined to 60-90 minutes even in the absence of MMS. Upon MMS treatment, 2 
the cds1? strain (B) showed a further decay of replication synchrony. These telomeric restriction 3 
fragments in the cdc25OP strain (C) replicated asynchronously in the absence as well as the 4 
presence of MMS. 5 
 6 
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